Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings. | Front Immunol | 2022 | 36172385 | PubTator, text mining | PubMed |
| Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis. | World J Surg Oncol | 2022 | 36171591 | PubTator, text mining | PubMed |
| The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. | Theranostics | 2022 | 36168628 | PubTator, text mining | PubMed |
| Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC. | Cell Death Dis | 2022 | 36167821 | PubTator, text mining | PubMed |
| Mechanisms of development and progression of pancreatic neoplasms. | Pathol Int | 2022 | 36161420 | PubTator, text mining | PubMed |
| Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases. | Case Rep Endocrinol | 2022 | 36160179 | PubTator, text mining | PubMed |
| Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma. | Front Immunol | 2022 | 36159831 | PubTator, text mining | PubMed |
| Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug-A Review. | Molecules | 2022 | 36144768 | PubTator, text mining | PubMed |
| Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer. | Diagnostics (Basel) | 2022 | 36140469 | PubTator, text mining | PubMed |
| Exploring the mechanism of action of licorice in the treatment of COVID-19 through bioinformatics analysis and molecular dynamics simulation. | Front Pharmacol | 2022 | 36120307 | PubTator, text mining | PubMed |
| Molecular pathways in glioblastoma-derived stem cells to identify effective drug agents: A bioinformatics study. | J Family Med Prim Care | 2022 | 36119333 | PubTator, text mining | PubMed |
| ALS-linked loss of Cyclin-F function affects HSP90. | Life Sci Alliance | 2022 | 36114006 | PubTator, text mining | PubMed |
| Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma. | Front Oncol | 2022 | 36110946 | PubTator, text mining | PubMed |
| Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets. | Front Pharmacol | 2022 | 36110540 | PubTator, text mining | PubMed |
| The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation. | Transl Cancer Res | 2022 | 36093542 | PubTator, text mining | PubMed |
| Autophagy Plays Multiple Roles in the Soft-Tissue Healing and Osseointegration in Dental Implant Surgery-A Narrative Review. | Materials (Basel) | 2022 | 36079421 | PubTator, text mining | PubMed |
| Predicting AURKA as a novel therapeutic target for NPC: A comprehensive analysis based on bioinformatics and validation. | Front Genet | 2022 | 36072667 | PubTator, text mining | PubMed |
| Aberrant mitochondrial homeostasis at the crossroad of musculoskeletal ageing and non-small cell lung cancer. | PLoS One | 2022 | 36067173 | PubTator, text mining | PubMed |
| Anti-colorectal cancer effects of seaweed-derived bioactive compounds. | Front Med (Lausanne) | 2022 | 36059851 | PubTator, text mining | PubMed |
| Transcriptional profiles define drug refractory disease in myeloma. | EJHaem | 2022 | 36051067 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=21